Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

NPPT (N-(n-propyl) Thiophosphoric Triamide) Urease Inhibitor Market to Reach $12.24 Billion by 2030 as Sustainable Agriculture Accelerates

July 22, 2026

Mamey Sapote Drinks Market to Reach $1.64 Billion by 2030 as Demand for Plant-Based Beverages Accelerates

July 22, 2026

DIVEVOLK SeaLink Supports Underwater Production for vivo S60’s “Starlight Luggage”

July 22, 2026

Bluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital Pharmacies

July 22, 2026

More than 170 wildfires burning in Ontario’s north

July 22, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » TIME Honors Vibrant’s Chronic Constipation Treatment Among 2023’s Best Inventions
Press Release

TIME Honors Vibrant’s Chronic Constipation Treatment Among 2023’s Best Inventions

By News RoomNovember 28, 20232 Mins Read
TIME Honors Vibrant’s Chronic Constipation Treatment Among 2023’s Best Inventions
Share
Facebook Twitter LinkedIn Pinterest Email

BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) — TIME has honored Vibrant, the groundbreaking drug-free treatment for chronic constipation by Vibrant Gastro, as part of its list of 2023’s Best Inventions.

Up to one in five American adults — disproportionately women and people of color — struggle to have bowel movements, and existing treatments ruin their quality of life. Traditional and prescription laxatives cause sudden on-set diarrhea — uncomfortable, uncontrollable and unpredictable. In fact, 60% of patients say the treatments are worse than the constipation itself.

“That’s not the case with the … Vibrant System — a prescription, non-pharmacological capsule programmed to vibrate eight to 10 hours after ingestion, when it reaches the large intestine,” writes TIME’s Katie MacBride. “The vibrations stimulate nerve cells involved in peristalsis, the process that pushes food through the digestive system. When the capsule’s work is done, it passes through the patient and is flushed away.”

Vibrant restores the colon’s natural rhythm and puts you back in control with consistent bowel movements at predictable times. Studies show that Vibrant has a low rate of side effects, with just 1.2% of patients reporting diarrhea. Since Vibrant is not a drug, there are no interactions with other drugs, unlike traditional and prescription laxatives.

“Being honored among TIME’s Best Inventions is further validation that Vibrant offers a real answer for the tens of millions of Americans whose lives are upended by chronic constipation,” said Vibrant Gastro CEO John Schellhorn. “The strong interest we’ve seen since Vibrant’s clearance by the FDA demonstrates how patients and physicians have long sought a real solution for a life-altering problem.”

About Vibrant
Up to 1 in 5 American adults — disproportionately women and people of color — struggle with chronic constipation and existing treatments ruin their quality of life with 60% saying the treatments, which cause diarrhea, are worse than the constipation. Vibrant is a new FDA-cleared drug-free treatment that uses a vibrating capsule to restore the colon’s natural rhythm and put you back in control. Clinical results show Vibrant provides one, two and sometimes three additional complete spontaneous bowel movements weekly, even in severe adult patients, with just 1.2% of patients reporting diarrhea. Since Vibrant’s not a drug, there are no interactions with other drugs, unlike traditional and prescription laxatives. Learn more at vibrantgastro.com.

Gallery of images available here

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4adeb8c0-4a0a-44ea-9157-d20e79c5f696

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

NPPT (N-(n-propyl) Thiophosphoric Triamide) Urease Inhibitor Market to Reach $12.24 Billion by 2030 as Sustainable Agriculture Accelerates

Mamey Sapote Drinks Market to Reach $1.64 Billion by 2030 as Demand for Plant-Based Beverages Accelerates

DIVEVOLK SeaLink Supports Underwater Production for vivo S60’s “Starlight Luggage”

Bluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital Pharmacies

Asprofin Bank and Digital TRVST Forge Banking-as-a-Service Alliance as Embedded Finance Nears $7 Trillion

Crypto Investors Watch Closely as Solana Unchained Reaches Its Last Day With Exclusive Bonuses, AI-Powered Features, and a New Utility-Driven Token Economy

Whitechapel Securities Reports Growing Client Demand for Diversified Investment Portfolios

FCC Veterans File Amicus Supporting Media and Democracy Project; Warn Commission Evading Judicial Review

Canadian Pet Parents Continue to Prioritize Pet Spending over their Everyday Pleasures

Editors Picks

Mamey Sapote Drinks Market to Reach $1.64 Billion by 2030 as Demand for Plant-Based Beverages Accelerates

July 22, 2026

DIVEVOLK SeaLink Supports Underwater Production for vivo S60’s “Starlight Luggage”

July 22, 2026

Bluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital Pharmacies

July 22, 2026

More than 170 wildfires burning in Ontario’s north

July 22, 2026

Latest News

Asprofin Bank and Digital TRVST Forge Banking-as-a-Service Alliance as Embedded Finance Nears $7 Trillion

July 22, 2026

The 2026 Honda Prelude is a marvel of hybrid technology

July 22, 2026

Crypto Investors Watch Closely as Solana Unchained Reaches Its Last Day With Exclusive Bonuses, AI-Powered Features, and a New Utility-Driven Token Economy

July 22, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version